Indications
Therapeutic Asset Ratings
9,920 results matching 1 filter
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Pebezertinib
Metastatic Malignant Neoplasm In The Brain
Blueprint Medicines Corporation
P1
CC
(43)
Pebezertinib
Hepatocellular Carcinoma
Blueprint Medicines Corporation
P1
CC
(43)
Pebezertinib
Non-Small Cell Lung Carcinoma
Blueprint Medicines Corporation
P1
CC
(43)
Pebezertinib
Lung Cancer
Blueprint Medicines Corporation
P1
CC
(43)
Pebezertinib
Neoplasm
Blueprint Medicines Corporation
P1
CC
(43)
Pebezertinib
Respiratory System Disorder
Blueprint Medicines Corporation
P1
CC
(43)
Pediatric Multitaa T Cells Stage
Hodgkins Lymphoma
Baylor College of Medicine
P1
CC
(43)
Pediatric Multitaa T Cells Stage
Non-Hodgkin Lymphoma
Baylor College of Medicine
P1
CC
(43)
Pegaspargase
B-Lymphoblastic Leukemia/Lymphoma, BCR-ABL1–Like
City of Hope Medical Center
P1
CC
(43)
Pegfilgrastim
Primary Effusion Lymphoma
National Cancer Institute (NCI)
P1
CC
(43)
Pegfilgrastim
Amyloidosis
Memorial Sloan Kettering Cancer Center
P1
CC
(43)
Pegfilgrastim
Nodal T-Follicular Helper Cell Lymphoma, Follicular Type
City of Hope Medical Center
P1
CC
(43)
Pegfilgrastim
High Grade B-Cell Lymphoma With MYC And/ Or BCL2 And/Or BCL6 Rearrangement
Mayo Clinic
P1
CC
(43)
Pegfilgrastim
Indolent B-Cell Non-Hodgkin Lymphoma
Mayo Clinic
P1
CC
(43)
Pegfilgrastim
Mature T-Cell And NK-Cell Non-Hodgkin Lymphoma
City of Hope Medical Center
P1
CC
(43)
Pegfilgrastim
Diffuse Large B-Cell Lymphoma Of The Central Nervous System
National Cancer Institute (NCI)
P1
CC
(43)
Pelcitoclax
Endometrial Carcinoma
National Cancer Institute (NCI)
P1
CC
(43)
Pelcitoclax
Non-Small Cell Lung Carcinoma
Ascentage Pharma Group Inc.
P1
CC
(43)
Pelcitoclax
T-Cell Acute Lymphoblastic Leukemia
M.D. Anderson Cancer Center
P1
CC
(43)
Pelcitoclax
Fallopian Tube Carcinoma
National Cancer Institute (NCI)
P1
CC
(43)
Pelcitoclax
Ovarian Carcinoma
National Cancer Institute (NCI)
P1
CC
(43)
Pelcitoclax
Primary Peritoneal Carcinoma
National Cancer Institute (NCI)
P1
CC
(43)
Pelcitoclax
Uterine Corpus Endometrial Carcinoma
National Cancer Institute (NCI)
P1
CC
(43)
Pelcitoclax
Uterine Corpus Cancer
National Cancer Institute (NCI)
P1
CC
(43)
Pembrolizumab
Skin Appendage Carcinoma
Memorial Sloan Kettering Cancer Center
P1
CC
(43)
Showing 3751 to 3775 of 9,920 assets
Previous
Page 151 of 397
Next